| Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors J Cros, N Cagnard, K Woollard, N Patey, SY Zhang, B Senechal, A Puel, ... Immunity 33 (3), 375-386, 2010 | 1501 | 2010 |
| X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 11 (4), 649-657, 2000 | 887* | 2000 |
| X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 11 (4), 649-657, 2000 | 670 | 2000 |
| X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 11 (4), 649-657, 2000 | 670 | 2000 |
| X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 11 (4), 649-657, 2000 | 670 | 2000 |
| Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion A Bourdon, L Minai, V Serre, JP Jais, E Sarzi, S Aubert, D Chrétien, ... Nature genetics 39 (6), 776-780, 2007 | 611 | 2007 |
| IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma RA Cairns, J Iqbal, F Lemonnier, C Kucuk, L De Leval, JP Jais, M Parrens, ... Blood, The Journal of the American Society of Hematology 119 (8), 1901-1903, 2012 | 545 | 2012 |
| X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted … JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 14 (10), 2603-2610, 2003 | 545 | 2003 |
| Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters F Lemonnier, L Couronné, M Parrens, JP Jaïs, M Travert, L Lamant, ... Blood, The Journal of the American Society of Hematology 120 (7), 1466-1469, 2012 | 481 | 2012 |
| Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised … C Récher, B Coiffier, C Haioun, TJ Molina, C Fermé, O Casasnovas, ... The Lancet 378 (9806), 1858-1867, 2011 | 439 | 2011 |
| Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy MJ Maurer, H Ghesquières, JP Jais, TE Witzig, C Haioun, CA Thompson, ... Journal of Clinical Oncology 32 (10), 1066-1073, 2014 | 399 | 2014 |
| Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker V Hofman, C Bonnetaud, MI Ilie, P Vielh, JM Vignaud, JF Fléjou, ... Clinical cancer research 17 (4), 827-835, 2011 | 373 | 2011 |
| Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial A Clement, A Tamalet, E Leroux, S Ravilly, B Fauroux, JP Jais Thorax 61 (10), 895-902, 2006 | 359 | 2006 |
| SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma RO Casasnovas, M Meignan, A Berriolo-Riedinger, S Bardet, A Julian, ... Blood, The Journal of the American Society of Hematology 118 (1), 37-43, 2011 | 328 | 2011 |
| Anti–B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome M Benkerrou, JP Jais, V Leblond, A Durandy, L Sutton, P Bordigoni, ... Blood, The Journal of the American Society of Hematology 92 (9), 3137-3147, 1998 | 323 | 1998 |
| Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 300 | 2017 |
| Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas D Vallois, MPD Dobay, RD Morin, F Lemonnier, E Missiaglia, M Juilland, ... Blood, The Journal of the American Society of Hematology 128 (11), 1490-1502, 2016 | 297 | 2016 |
| C57BL/6J and A/J mice fed a high‐fat diet delineate components of metabolic syndrome C Gallou‐Kabani, A Vigé, MS Gross, JP Rabès, C Boileau, ... Obesity 15 (8), 1996-2005, 2007 | 295 | 2007 |
| Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection S Kayal, JP Jais, N Aguini, J Chaudiere, J Labrousse American journal of respiratory and critical care medicine 157 (3), 776-784, 1998 | 284 | 1998 |
| MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study C Copie-Bergman, P Cuillière-Dartigues, M Baia, J Briere, R Delarue, ... Blood, The Journal of the American Society of Hematology 126 (22), 2466-2474, 2015 | 276 | 2015 |
